Eli Lilly & Co (NYSE:LLY) Shareholder Dodge & Cox Upped Its Position as Price Declined

May 17, 2018 - By Mark Mitchell

Eli Lilly and Company (NYSE:LLY) Corporate LogoDuring Q4 2017 the big money sentiment increased to 1.1. That’s change of 0.21, from 2017Q3’s 0.89. 42 investors sold all, 380 reduced holdings as LLY ratio increased. 346 increased positions while 117 funds acquired positions. Funds hold 827.08 million shares thus 0.09% less from 2017Q3’s 827.83 million shares. James Invest Research Inc stated it has 0% of its capital in Eli Lilly and Company (NYSE:LLY). 11,333 were reported by Highland Mngmt Ltd Company. 4,400 are held by Loring Wolcott And Coolidge Fiduciary Advsr Ltd Liability Partnership Ma. 13,838 are held by Hodges Cap Mgmt Inc. Moreover, Advantus Cap Management has 0.21% invested in Eli Lilly and Company (NYSE:LLY) for 98,828 shs. Rmb Cap Management Limited Liability holds 0.03% or 14,159 shs in its capital. Signaturefd Llc accumulated 5,155 shs. Pnc Financial Serv Inc accumulated 1.74 million shs. Hyman Charles D holds 0.05% or 5,300 shs. Planning Advsrs Limited Liability stated it has 0.4% of its capital in Eli Lilly and Company (NYSE:LLY). Cardinal holds 1.24% of its capital in Eli Lilly and Company (NYSE:LLY) for 48,618 shs. Blue invested in 0.64% or 13,059 shs. Nuwave Lc reported 1.52% in Eli Lilly and Company (NYSE:LLY). Coastline, a Rhode Island-based fund reported 14,502 shs. Commonwealth National Bank Of Australia holds 0.06% in Eli Lilly and Company (NYSE:LLY) or 77,869 shs.

LLY registered $48.49 million net activity with 0 insider purchases and 11 selling transactions since December 11, 2017. Another trade for 180,000 shs valued at $14.55 million was made by LILLY ENDOWMENT INC on Wednesday, April 25. $1.08 million worth of Eli Lilly and Company (NYSE:LLY) was sold by Simmons Jeffrey N. On Friday, March 16 Smiley Joshua L had sold 3,000 shs worth $237,600. 22,544 shs were sold by Mahony Susan, worth $1.81 million on Friday, April 13.

In 2018Q1 SEC regulatory report was reported Dodge & Cox’s stake in Eli Lilly & Co (NYSE:LLY) which was increased by 8.23%. Eli Lilly & Co (NYSE:LLY) declined 11.06% with the market as Dodge & Cox bought 1.66M shares. It held 21.84 million shares of Eli Lilly & Co (NYSE:LLY) at the end of 2018Q1, valued at $1.69B, up from 20.18M last quarter. $82.86 billion is the Eli Lilly & Co’s market cap. LLY reached $81.18 during the last trading session after $0.47 change.Currently Eli Lilly and Company is downtrending after 10.19% change in last May 17, 2017. LLY has also 3.61M shares volume. LLY underperformed by 21.74% the S&P 500.

The Dodge & Cox’s stake in Concho Resources Inc (NYSE:CXO) was reduced by 1.07M shares to 4.59M shares valued at $690.18 million in 2018Q1, according to the regulatory report. It operates about $123.87 billion US longs. Dodge & Cox cut its stake in Capital One Financial Corp (NYSE:COF) and reduced Jd.Com Inc (NASDAQ:JD) position by 6.12 million shares for a total of 21.59M shares.

Dodge & Cox is a California-based institutional investor with more than $224.00 billion AUM in October, 2014. This fund invests only a small percentage of its assets in equities and options. Dodge & Cox is the 15th largest institutional investor in our database. Taken from Dodge & latest Adv, the fund reported to have 205 full and part-time employees. Among which 85 performing investment advisory and research functions. The institutional investor had more than 500 clients.

Eli Lilly and Company (NYSE:LLY) Ratings Coverage

In total 10 analysts cover Eli Lilly (NYSE:LLY). “Buy” rating has 4, “Sell” are 1, while 5 are “Hold”. (NYSE:LLY) has 40% bullish analysts. 17 are the (NYSE:LLY)’s ratings reports on 17 May 2018 according to StockzIntelligence Inc. The company rating was downgraded by Credit Suisse on Monday, January 22. The company rating was maintained by Bank of America on Thursday, February 1. On Thursday, February 1 BMO Capital Markets maintained Eli Lilly and Company (NYSE:LLY) rating. BMO Capital Markets has “Underperform” rating and $74 target. The stock rating was downgraded by Goldman Sachs to “Hold” on Tuesday, January 16. On Thursday, February 1 Leerink Swann maintained Eli Lilly and Company (NYSE:LLY) rating. Leerink Swann has “Hold” rating and $98.0 target. On Tuesday, January 16 the company was maintained by Jefferies. On Wednesday, December 13 the stock of Eli Lilly and Company (NYSE:LLY) earned “Hold” rating by Leerink Swann. On Friday, January 5 the firm earned “Buy” rating by Argus Research. On Tuesday, November 21 Morgan Stanley maintained Eli Lilly and Company (NYSE:LLY) with “Equal-Weight” rating. On Monday, February 26 the stock of Eli Lilly and Company (NYSE:LLY) has “Buy” rating given by Jefferies.

Eli Lilly and Company discovers, develops, makes, and markets pharmaceutical products worldwide.The firm is worth $82.86 billion. It operates through two divisions, Human Pharmaceutical Products and Animal Health Products.Currently it has negative earnings. The firm offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency.

Eli Lilly and Company (NYSE:LLY) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: